Edit Várkondi

Epidermal Growth Factor Receptor (EGFR) High Gene Copy Number and Activating Mutations in Lung Adenocarcinomas Are Not Consistently Accompanied by Positivity for EGFR Protein by Standard Immunohistochemistry

Ferenc Pintér, Judit Pápay, Andrea Almási et al. · Journal of Molecular Diagnostics · 2008 · 63 citations · Full text

Medicine, Genetics, Oncology +16

Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement

Richárd Schwab, István Peták, Mihaly Kollar et al. · Lung Cancer · 2013 · 60 citations

Medicine, Oncology, Pharmacology +17

A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial

István Peták, Maud Kamal, Anna Dirner et al. · npj Precision Oncology · 2021 · 27 citations · Full text

Medicine, Bioinformatics, Oncology +17

Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers

Diána Brauswetter, Bianka Gurbi, Attila Varga et al. · PLoS ONE · 2017 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Structure−Activity Relationship Studies Optimizing the Antiproliferative Activity of Novel Cyclic Somatostatin Analogues Containing a Restrained Cyclic β-Amino Acid

Martin Sukopp, Richárd Schwab, Luciana Marinelli et al. · Journal of Medicinal Chemistry · 2005 · 23 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16